|David Shurtleff, Ph.D.||
Acting Deputy Director, NIDA
|Ana Anders, L.I.C.S.W.||Senior Advisor on Special Populations||301-443-0441|
|Pamela Goodlow||Public Health Analyst||301-435-0925|
|Flair Lindsey||Program Analyst||301-435-0779|
David Shurtleff, Ph.D.
Dr. David Shurtleff serves as the Acting Deputy Director of the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH). In this capacity, Dr. Shurtleff is responsible for providing leadership in the development, implementation, and management of NIDA’s research portfolio and strategic priorities and assists the Director of NIDA to support and conduct research to improve prevention and treatment of drug use, abuse and addiction. Prior to his current appointment, Dr. Shurtleff served as the Director of the Division of Basic Neuroscience and Behavioral Research (DBNBR). In this role, he oversaw the scientific direction of the Division to primarily support basic biomedical and behavioral science research that relates to the public health problem of drug abuse and addiction.
Ana Anders, L.I.C.S.W.
Ana Anders is a Senior Advisor on Special Populations in the Office of Special Populations, where she has administrative as well as programmatic responsibilities in the design, development and implementation of the Institute’s Hispanic Initiative and Asian and Pacific Islander Initiative. Ms. Anders designed, developed and implemented the National Hispanic Science Network on Drug Abuse (NHSN), whose mission is to foster science on drug abuse among Hispanics and its application to clinical and public health practice. The NHSN is unique in its mission, objectives and approach: no comparable formal, structured science network exists outside the federal government that is dedicated to systematically increase the participation of Hispanic students and investigators in drug abuse research. Prior to her present position, she served as Special Assistant to the Administrator of the Substance Abuse and Mental Health Services Administration. She has extensive experience in the substance abuse prevention field as well as in mental health.
Pamela Goodlow has served as a public health analyst in NIDA’s Special Population Office since 1994. She is the expert coordinator for the Institute’s Research Supplements to Promote Diversity in Health-Related Research (Diversity Supplements) program, and is the Institute’s contact for the Diversity-promoting Institutions Drug Abuse Research Program (DIDARP). In addition, she chairs NIDA’s internal workgroup on minority issues, the NIDA Consortium on Minority Affairs. Until recently, Ms. Goodlow coordinated NIDA’s Special Populations Research Development Seminar Series. Prior to coming to the Special Populations Office, Ms. Goodlow served as Public Affairs Specialist in the former Community and Professional Education Branch (OSPC) at NIDA.
Flair Lindsey is a program analyst in NIDA’s Special Populations Office. Her numerous responsibilities include coordinating NIDA’s Special Populations Research Development Seminar Series for new investigators and the Summer Research with NIDA program for high school and undergraduate students. In addition, Ms. Lindsey manages the SPO’s logistics contract, which provides support to various NIDA and SPO-related activities. Since joining NIDA in 1995, Ms. Lindsey has been involved in the planning and coordination of meetings and activities relevant to health disparities research.
Charlotte Annan joined the Special Populations Office in 2002. Ms. Annan handles all of the office’s administrative needs, which include scheduling program activities for the SPO, maintaining files of SPO programs, arranging all staff travel, assisting with the coordination of diversity supplement application reviews, and the activities of the Summer Research with NIDA program. She brings over 35 years of administrative experience, including 20 years in the Federal government, to the SPO.